MedPath

Effect of L - carnitine in patients with hyperlipidemia

Not Applicable
Conditions
Hyperlipidemia.
Hyperlipidemia
Registration Number
IRCT2014011411920N2
Lead Sponsor
Baqiyatallah University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

risk of hyperlipidemia in the diagnosis and referral specialist measure cholesterol = 200 mg dL; triglycerides = 200 mg per deciliter;aged between 20 and 65 years; Gender (Female and Male)
Exclusion criteria: hypothyroidism; Pregnancy & menopause;smoking;drugs and alcohol;inflammatory diseases; such as diabetes; cancer; chronic liver disease (Fatty Liver, Cirrhosis of the liver, hepatitis, etc.) and use of Anti-seizure drugs; anti-supplements oxidant.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ipid Profile ( Tg,Total Chol, LDL-C, HDL-C ). Timepoint: Baseline and the end of the eighth week. Method of measurement: Their past record of blood test with automated analyzers.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath